I. INTRODUCTION
the hormones multifunctional regulators of general physiological interest. Hence, gastrointestinal hormones may Gastrointestinal hormones are by all criteria ordinary at the same time act as acute metabolic hormones, as hormones. Nevertheless, they have never been fully ac-neurotransmitters, as local growth factors, and as fertility cepted in endocrinology. Endocrinology textbooks and factors. This widespread gene expression with tissue-spegeneral endocrinology meetings witness how gastrointes-cific prohormone processing combined with differential tinal hormones often occupy only little room in today's functions constitutes essential parts of what may be conconcept of endocrinology. The restrained acceptance is a ceived as a new and fascinating biology, which should paradox in three ways. 1) Endocrinology was conceptu-appeal also to general endocrinology and physiology. ally put on a firm scientific footing in the gut with the The basic concept of endocrinology, blood-borne regdiscovery of secretin (12, 13) and with the subsequent ulation by specific messenger molecules, was discovered introduction of the word hormone (227) .
2) The gut is in 1902 by the British physiologists William Maddox Baythe largest hormone-producing organ in the body, both in liss and Ernest Henry Starling (12, 13) . Following up on terms of number of endocrine cells and number of hor-the observation of Pavlov and co-workers, that acidificamones (for comprehensive reviews, see Refs. 211 and tion of the upper intestine resulted in secretion of pancre-251).
3) The widespread expression of gastrointestinal atic juice (for review, see Ref. 178 ), Bayliss and Starling extracted from the duodenal mucosa a substance, which hormone genes outside the gastrointestinal tract makes For the sake of completeness, it should be added transcript to express CGRP is not the only example (3) . Also, the secretin gene is expressed in different molecular here that a number of monoamines (including histamine and dopamine) and various eicosanoids with hormonelike forms in the gut because of alternative splicing (84, 131) .
Additional features contributing to the plurality are activities also are produced in the gastrointestinal tract. This review is, however, restricted to proper gut hor-physiological studies which have indicated that there still are gut hormonal activities that are not easily explained mones, which are peptides. It should also be emphasized that the designations gastrointestinal hormones and gut by known peptides and, therefore, require identification of new hormones. Hence, as shown in Figure 1 , 10 hormonal hormones are used synonymously in this review.
factors are still awaiting structural determination of both peptides and genes. Perhaps some of them can be partly III. THE NEW CONCEPTS explained by identified peptides. Hence, the incretin effect (135, 155) is probably exerted by a combination GIP (66) and GLP-I (54, 109) stimulations, whereas the entero-, A. Many Hormones and Their Families vago-, and bulbogastrone effects may be explained by various combinations of somatostatin, GIP, EGF, and TGFGastrointestinal endocrinology has since 1970, when it was confined to only three identified peptides (91, 166 , a. However, villikinin, duo-and enterocrinins, and the recently suggested gastrocalcin (181) still await a struc-167), virtually exploded in number of regulatory gut peptides, i.e., hormones, peptide transmitters, and growth fac-tural identification of new substances, most probably peptides. tors ( Fig. 1 ). Not only have new peptides with all features of a hormone been found in gut extracts [gastric inhibitory
It may be difficult to overlook the multiplicity of the gut peptide systems. The structural identifications, howpolypeptide (GIP), Refs. 32, 34, 36; motilin, Refs. 31, 33, 35, 210; peptide tyrosine tyrosine (PYY), Refs. 236, 237; ever, have simplified the matter by showing striking homologies between groups of peptides. Consequently, onegalanin, Refs. 72, 238; glucagon-like peptides (GLPs), Refs. 16, 109, 176, 177, 234, 239, 245], but also neuropeptides half of the hormones can be classified in families based on homology. Table 1 shows the major gastro-entero-panisolated from the central nervous system and hormones identified first in other endocrine organs have been found creatic hormone families. The expression of several peptide genes both in the gut and the pancreas reflects that to be present in endocrine cells and/or neurons in the gastrointestinal tract [substance P, Refs. 43, 46, 71 (Fig. 2) . The extensive similarity of the primary structures is coupled to 205, 241]. Moreover, potent regulatory peptides originally believed to be classical hormones but later shown to be an almost identical and stable tertiary structure because the homology explicitly comprise residues, which are imwidespread neurotransmitters have been isolated from gut extracts [vasoactive intestinal polypeptide (VIP), Refs. portant for stabilization of the three-dimensional PP-fold structure (88) . The PP-fold motif consists of a polyproline-137, 168, 207; peptide histidine isoleucine, Refs. 20, 114, 148, 237; and gastrin-releasing peptide (GRP), Refs. 153, like helix (residues 1-8) and an amphiphilic a-helix (residues 15-30). The two helixes are joined by a type I b-154, 156, 160]. Finally, a number of growth factors with hormonal effects have now been shown to be present in turn (residues 9-12) and held in the folded configuration by hydrophobic interdigitations between side chains of the gut: epidermal growth factor (EGF), originally isolated as a gut hormone; urogastrone, from urine independently the a-helix residues and the NH 2 -terminal proline residues (Fig. 2) . Not only are the bioactive 36-amino acid peptides of Cohen's EGF identification (49, 50) , the isolation being monitored by its effect on gastric acid secretion by Harold in the family highly homologous, the cDNA-deduced prepropeptides also display remarkable similarities in their Gregory (90) ; insulin-like growth factor I and II (30, 56, 209, 229) ; transforming growth factor (TGF)-a and -b (14, organization (21, 147, 157) .
Another type of homology is that of the gastrin family 44, 134, 250); and amphiregulin (182) .
The complexity is further increased by the fact that (Table 1 and Fig. 3 ). The family comprises, in addition to the mammalian hormones, gastrin and CCK, also the individual genes for gut regulatory peptides encode different peptides, which in a tissue-and cell-specific manner protochordean neuropeptide cionin (120), and the frog skin peptide cerulein (4 , and open circles indicate hormonal activities, which still require identification of responsible hormone(s). Some of structurally unidentified hormonal activities can be partly explained by activity of later identified hormones; for instance, incretin activity is partly due to gastric inhibitory polypeptide (GIP) and glucagon-like peptide I (GLP-I) activities. Commonly used acronyms are indicated in brackets after full name, except for PACAP, which is an acronym for pituitary adenylate cyclase-activating peptide.
ide -Trp-Met-Asp-Phe-NH 2 (the box in Fig. 3 ). Any modifi-regulatory peptides in the gut. On the contrary, it is common among all kinds of regulatory peptides, enzymes, and cation of this site grossly reduces or abolishes the receptor binding and consequently the biological effects of the other proteins in the organism (for reviews, see Refs. 1, 64, 65, 118, 260) . Each family is assumed to reflect the hormones (162). Comparison of propeptide and gene structures reveals a complex pattern with an overall simi-phylogenetic evolution by duplication and subsequent mutations of an ancestral gene. It is, however, possible that larity in the organization of progastrin, proCCK, and procionin as well as their genes (22, 57, 58, 161, 203, 256, 257 , the homology not only reflects divergent evolution. The occurrence of homologous peptides in submammalian 259), but with only little similarity in the amino acid residues and DNA sequences outside the sequence corre-species may also demonstrate the existence of several related genes, of which some do not evolve into genes of sponding to the common active site and its COOH-terminal flanking peptide. Hence, this family is in contrast to the mammalian species or of other vertebrates.
The question of phylogenetic origin has recently PP-fold family and the secretin family primarily defined by the conserved active site sequence and by the neighboring been examined in detail for the gastrin family by Johnsen (118). His study tested an immunochemically based O-sulfated tyrosyl residues (Fig. 3) .
The frequent occurrence of homology among gastro-hypothesis suggesting that CCK and gastrin originate from a single common ancestral gene, which during evointestinal hormones, peptide neurotransmitters in the gut, and intestinal growth factors is not a feature specific for lution duplicated into separate CCK and gastrin genes express gastrins with a structure that differs grossly from CCK outside the active site sequence (22, 118, 259). The phylogenetic story of the gastrin family shows at the level of reptiles (140) . Identification of peptides that gastrointestinal hormones indeed are very old. So far, from brain and gut tissues of species representing the the data also support the idea that each gut peptide family entire animal kingdom (including invertebrates) showed, has evolved from a single ancestor. An associated trait is however, the following: so far it has not been possible in that gastrointestinal hormones, at least in the gastrin family, to a large degree have preserved their tissue-specific invertebrates to identify true CCK-/gastrin-like peptides sites of expression during evolution, both primary and described later for gastrin, true molecular heterogeneity most often reflects an elaborate posttranslational phase of secondary sites (206) . Accordingly, both the structural and cell-specific evolutionary conservation emphasize the the expression cascade, which results in cellular synthesis and release of several different forms of a hormone. Angeneral biological significance of gut hormones.
other and apparently less common way in which a gene can express different molecular forms is by alternative B. Multiple Phenotypes of a Hormone Gene splicing of RNA transcripts.
Alternative splicing, as a mechanism by which pep-A quarter of a century ago, gastrointestinal endocri-tide hormone complexity increases, was discovered 15 nology was, as mentioned, believed to comprise three dif-years ago, when Amara and co-workers (2, 3, 205) showed ferent peptides (secretin, gastrin, and CCK). At that time that calcitonin gene transcription generates different it was also believed that one gene encoded one hormonal mRNA encoding either calcitonin peptides or CGRP. It molecule, in accordance with what was learned about the is now also well established that CGRP are abundantly master hormone, insulin. In other words, one gene equals expressed in intestinal neurons throughout the digestive one hormonal peptide. The complexity of gastrointestinal tract (164, 241; for review, see Ref. 110). Hence, alternaendocrinology first grew in a straightforward manner with tive splicing does play a significant role in the control of the discovery and recognition of new hormones (Fig. 1) . digestive functions. However, the synchronous rapid development in peptide
The calcitonin gene is, however, not the only gene chemistry and molecular biology soon added new and encoding a gut peptide, which expresses itself by alternamore intricate dimensions to the complexity. The ''one tive splicing. The alternative splicing of a tachykinin gene gene, one hormonal peptide'' dogma turned out to be too (171) and also one of the peptides encoded by the secretin simplistic for many gut hormones. Instead, and concur-gene is a result of alternative splicing of the primary tranrently with the elucidation of eukaryotic gene structures scripts (84, 131). and improved understanding of the mechanisms governFor many years, secretin was believed to exist only ing gene expression cascades, it became obvious that hor-as a carboxyamidated peptide of 27 amino acid residues mone genes often express several different bioactive pep-(166, 167). However, in the mid 1980s, two additional setides. Exactly which peptides appear to be regulated in a cretins with full bioactivity were identified in porcine gut cell-specific manner? Today we know three different ways extracts. One was the immediate precursor of amidated in which a gastrointestinal hormone gene can express secretin-27, i.e., glycine-extended secretin-28 (41) , and the different bioactive peptides (Fig. 4) .
other was secretin-30 extended by a Lys-Arg sequence (83) . In contrast to members of the gastrin, tachykinin,
Alternative splicing of transcripts
and PP-fold families (Table 1 and Figs. 2 and 3) , COOHterminal extensions of the amidated end products of seExistence of different molecular forms of a gut horcretin, VIP, and other members of the secretin family do mone or of an intestinal peptide neurotransmitter is quite not eliminate or reduce the bioactivity, because the activcommon. It is important to emphasize, however, that the ity resides mainly in the NH 2 terminus of the peptides. concept of molecular heterogeneity only refers to the exis-
The existence of glycine-and glycyl-lysyl-arginine-extence of more than one bioactive form. The coexistence tended forms of secretin and VIP is not surprising. They of more or less inactive prohormones and processing inare in fact to be expected from what is known about the termediates and/or degradation fragments with a single proper hormone, as well known for insulin, is trivial. 4 . Multiple phenotypes (molecular heterogeneity) of 3 gut hormone genes. The cholecystokinin (CCK) gene encodes a prepropeptide, which through differentiated endoproteolytic cleavages is processed to 6 CCK peptides varying in length from 83 to 8 amino acid residues. The six peptides have the same COOH-terminal bioactive octapeptide sequence (see also Fig. 3 ). The secretin gene encodes a prepropeptide that through endoproteolytic cleavages and variable COOH-terminal trimming is processed to 3 bioactive secretin peptides of almost similar size (secretin-27, -28, and -30). In addition, bioactive secretin-71 is produced by splicing out RNA encoding midsequence of preprosecretin (i.e., broken line of secretin-71). The glucagon gene encodes a prepropeptide that through cell-specific endoproteolytic cleavages is processed to either genuine pancreatic glucagon (in pancreatic acells) or to glucagon-like peptides I and II (GLP-I, GLP-II; in intestinal L cells).
was, however, the discovery of secretin-71 (84), which lengths with the same bioactive COOH terminus are synthesized (Table 2) . Although the different bioactive prodcontains the sequence of nonamidated secretin-27 NH 2 terminally, followed by a Gly-Lys-Arg extension and a fur-ucts of the same precursor are bound to the same receptor, their varying metabolic clearances from plasma affect ther COOH-terminal extension of 41 amino acid residues (Fig. 4) . With the exception of an arginine residue, which their hormonal significance considerably. Hence, it matters indeed whether intestinal proCCK is processed follows the Gly-Lys-Arg sequence directly, the COOH-terminal sequence of secretin-71 is identical to the COOH-mainly to CCK-58 or to CCK-8 or whether prosomatostatin is processed to somatostatin-28 or -14. terminal 40 amino acid residue fragment of porcine preprosecretin (Fig. 4) . Thus what corresponds to secretin So far, the processing of progastrin in antral G cells has been examined particularly thoroughly. It will there-RNA encoding a 32-amino acid sequence has been spliced out from the primary secretin gene transcript. For reasons fore be used to illustrate the second way in which one gastrointestinal hormone gene can encode different bioacmentioned above, secretin-71 has full secretin bioactivity. It remains to be settled how large a fraction secretin-71 tive peptides.
In vertebrates, antral G cells synthesize by far most constitutes of the circulating secretins. The large molecular size suggests a slow metabolic clearance from blood. of the gastrin of the total organism (Table 3) . Through a combination of knowledge about progastrin structure (22, Secretin-71 should therefore accumulate in plasma and constitute a significant fraction. It also remains to be set-80, 82, 85, 123, 149, 206, 259, see also Fig. 5 ), classic biotled how common alternative splicing of the primary secretin gene and other gastrointestinal hormone gene tran- As a result of the elaborate biosynthetic pathway, the normal antral G cells in humans release a heterogeOrders of magnitude are based on examination of different mamneous mixture of progastrin products from the mature malian species in the laboratory of the author (10, 26, 28, 79, 89, 117, 150, 151, 185, 186, 189, 191, 193, 196, 197, 199, 221, 222, 244) . secretory granules. A small percentage are nonamidated precursors, mainly glycine-extended gastrins. However, in humans, more than 90% are a-amidated bioactive gastrins of which the longest molecular form is gastrin-71 synthesis studies (28, 62, 106, 230, 246, 247), identification of progastrin products in antral extracts (91, 93, 94, 192, (194) . Of the amidated gastrins, 90% are gastrin-17, 5%
are gastrin-34, and the rest is a mixture of gastrin-71, 194), and modern cell biology (38, 40) , the biosynthetic pathway and the way in which G cells provide different -52, -14, and short COOH-terminal hepta-and hexapeptide amide fragments (92, 104, 117, 151, 192, 194, 196 , gastrins are now well established (Fig. 6) .
After translation of gastrin mRNA in the rough endo-199). Approximately one-half of the amidated gastrins are tyrosyl sulfated (5, 6, 28, 94, 106) . Because of major plasmic reticulum and cotranslational removal of the NH 2 -terminal signal peptide from preprogastrin, intact progas-differences in metabolic clearance rates, the distribution of gastrins in peripheral plasma changes so that larger trin is transported to the Golgi apparatus. In the transGolgi network, the first posttranslational modifications gastrins with their long half-lives predominate over gastrin-17 and shorter gastrins (117) . occur. These are O-sulfation of the tyrosyl-66 residue neighboring the active site and the first of the endoproteoIncreased gastrin synthesis changes the molecular pattern further. Abnormally increased antral synthesis oclytic prohormone convertase cleavages. From the transGolgi network, vesicles carry the processing intermedi-curs by achlorhydria, as seen in pernicious anemia. In antrum-sparing pernicious anemia, the translational activates of progastrin toward the basal part of the G cells, where the gastrin peptides are stored in characteristic ity of gastrin mRNA in the G cells seems to be so high that the enzymes responsible for the processing of progastrin secretory granules (61, 76, 97, 141, 163, 183) . We assume that the endoproteolytic prohormone convertase cleav-cannot keep up with the maturation, i.e., the carboxyamidation process (117) . Consequently, G cells release more ages at two monobasic and three dibasic processing sites (59, 152, 212, 216, 217, 228) and exoproteolytic carboxy-unprocessed and incompletely processed nonamidated progastrin products when the synthesis is increased. Also, peptidase E trimmings (77, 78) as well as the subsequent glutaminyl cyclization (75), corresponding to the NH 2 ter-the carboxyamidated gastrins are less sulfated (7), and the NH 2 terminus of progastrin is less cleaved (117) . Preminal of gastrin-34 and gastrin-17, continue during the transport from the Golgi to the early secretory granules. cursors, processing intermediates, and long-chained carboxyamidated gastrins, such as gastrin-71, gastrin-52, and The last and decisive processing step in the synthesis of gastrin then occurs during storage and maturation in the gastrin-34, are, as mentioned, cleared at a relatively slow rate from the circulation and therefore accumulate in secretory granules. The secretory granules contain the amidation enzyme complex (peptidylglycine a-amidating plasma when synthesis and release are increased. Therefore, assays that measure progastrin and its products irremonooxygenase or PAM, Refs. 59, 60, 69, 106), which removes glyoxylate from the immediate precursors, the gly-spective of the degree of processing provide a better mea- (11) .
illustrate the phenomenon. Some of the genes not only encode a peptide precursor containing different bioactive peptides, which is then subjected to tissue-specific post-3. Differential processing of prohormones containing translational processing, but the primary transcripts of two or more active sequences these gene(s) may also undergo tissue-specific alternative A third way in which expression of one gene can splicing (171). produce different bioactive peptides occurs when the Preproglucagon is an example of a poly-protein pregene encodes a propeptide containing different but often cursor, which in mammals contains three similar but still homologous peptide hormones or neuropeptides (Fig. 4) . different peptide sequences (Fig. 4) . In the a-cells of the Gut neuroendocrinology comprises many examples of pancreatic islets, proglucagon is processed to release the such genes of which the opioid-peptide genes (51, 96, 126, well-known pancreatic glucagon, whereas the COOH-terminal part of proglucagon remains silent in the sense that 169, 175), some of the tachykinin genes (133, 184, 186, 187, 193, 196, 198 ).
* Cholecystokinin peptides are present in spermatozoa of nonhuman mammals. The concentration, however, studies showed, however, that the first deduced and prohas not been quantitated.
posed GLP-I (proglucagon 72-107), which is situated between two dibasic sites in the precursor, is a poorly active peptide (108, 109). Instead, a truncated form of the origicess in the end results in a bioactive product. It is in fact nal GLP-I, which corresponds to the proglucagon senot unusual to see gene transcription without the encoded quence 78-107, turned out to be a highly potent glucorebioactive end product. Accordingly, reports on lack of gulatory peptide (109). Moreover, it is the shorter fragparallelism and synchrony between the occurrence of ment 78-107 that is synthesized and secreted in the gut mRNA, propeptide, and the mature bioactive peptide are (109, 176) and that therefore is the genuine GLP-I horsteadily increasing (for review, see Ref.
188; see also Tamone. The lesson of this story is, consequently, that bioacbles 3-5). Hence, in discussions of the often widespread tive peptide structures cannot be predicted from cDNA expression of the genes for peptide hormones and other and precursor sequences. It requires also precise identifiregulatory peptides in ''new'' sites in the body, it is necescation of the released peptides accompanied by proper sary to specify the sense in which the term expression is physiological studies of their activities.
meant. Especially in a physiological context, it becomes important to know whether transcription results in a bio-C. Widespread Gene Expression active product. Otherwise, what, for instance, is the physiological significance of the abundant but untranslated secretin mRNA in the colorectal mucosa (131; Table 5 )? In The term gene expression is widely used. Unfortuother words, it is not possible to conclude that mRNA nately, however, it is also broad and is often used in an occurrence means synthesis of functionally active unspecific manner. Sometimes it refers only to demonstrapeptides. tion of mRNA molecules, irrespective of whether the mesAll gut hormones are widely expressed in tissues outsage is translated or not. On other occasions, it refers to side the gastrointestinal tract, also phenotypically in terms synthesis of the primary translational product, irrespecof bioactive peptides. For some, the extraintestinal extive of whether the protein product is processed to a funcpression is confined mainly to neuroendocrine cells, espetionally active form. Finally, it may be used in a more cially to neurons in the central and peripheral nervous phenotypic sense to indicate the presence of the protein systems. However, several gastrointestinal hormones are or peptide in its bioactive form, i.e., the phenotypic end expressed also in other cell types and tissues (Tables 3-point of expression. 5). The literature on extraintestinal expression of gut horFor gastrointestinal hormones and other regulatory mones is by now overwhelming. Therefore, the phenomepeptides, the expression cascade is generally highly elabonon will be illustrated with two examples only, namely, rate and involves multiple enzymatic steps. Each of these steps may control whether the initial transcription pro-gastrin and CCK. Also, only sites of expression will be P6-8 / 9j0c$$oc05 09-24-98 13:48:59 pra APS-Phys Rev (52, 184) . Cholecystokiwidely and promiscuously in many different cell types, whereas CCK exemplifies extraintestinal expression re-nin peptides are also widely expressed in peripheral neurons, primarily in the intestinal tract, but also in the genistricted to neuroendocrine cells.
The gastrin gene is as mentioned expressed at the tourinary tract and elsewhere (142). Low-level expression has been found in pituitary corticotrophs (186, 187) , peptide level in several other cell types than the antroduodenal G cells. Quantitatively, these other cells produce in thyroid C cells (195) , in the adrenal medulla (9) , in the bronchial mucosa (86) , and in spermatogenic cells only little of the gastrin released to blood in normal organisms. This is partly because the extra-antral secretion of certain species (180) .
Although neuronal CCK peptides act as potent transseems to serve local purposes rather than a general endocrine purpose, and partly because the biosynthetic pro-mitters in central and peripheral synapses, the roles, if any, of CCK peptides in pituitary, thyroid, and adrenal cessing often is cell specific, i.e., so different from that of the antral G cells that bioactive amidated gastrin may endocrine cells are unknown. Neuronal CCK peptides seem to play decisive roles in the development of anxiety not even be synthesized. So far, we have encountered expression of progastrin and its products outside antrodu-and panic disorders in humans and other mammals (23-25, 190) as well as some role in satiety disorders (87, 218) . odenal mucosa in the distal small intestine, perhaps originating from the so-called TG cells (37, 79, 141) ; in unidenti-The exact molecular and neuronal mechanisms in these disturbances remain to be clarified. fied cells in the colorectal mucosa (150, 151) ; in endocrine cells in the fetal and neonatal pancreas (10, 26, 144) ; in A striking difference in the cellular expression of the otherwise homologous gastrin and CCK genes (57, 256) pituitary corticotrophs and melanotrophs (143, 185, 197) ; in oxytocinergic hypothalamopituitary neurons (184, 186 , is the high degree of promiscuity in the expression of the gastrin gene. Cholecystokinin peptides are, with the 193); in a few cerebellar (189) and vagal neurons (244) ; in the adrenal medulla of some species (unpublished re-exception of germ cells (180) , apparently never synthesized outside endocrine cells or neurons. Also, when it sults); in the bronchial mucosa (191) ; in postmenopausal ovaria (222) ; and in human spermatogenic cells (208). As comes to neoplasia, benign as well as malignant, CCK peptides only occur in tumors of neuroendocrine origin shown in Table 3 in the relatively rare neuroendocrine tumors but also in notypic result of hormone gene transcription is unpredictsignificant amounts in common carcinomas such as bron-able. It depends on the particular cell in which the gene is chogenic, colorectal, gastric, pancreatic, and ovarian can-transcribed. One of the variable phases in the expression cers (48, 89, 173, 191, (221) (222) (223) ; for review, see Ref. 200) . cascade is that of prohormone maturation, the posttransInterestingly, local expression of the gastrin receptor lational phase. Hence, the cellular equipment with proseems to accompany the widespread expression of gastrin cessing enzymes and the necessary cofactors determines peptides in cancers (201, 202) .
the structure of the particular prohormone product. This The definitive molecular explanation(s) of the differ-cell-specific processing of prohormones applies to all gasent extraintestinal expression patterns for CCK, gastrin, trointestinal hormones. and other gut hormones remains to be found. Part of the As in many physiological and clinical contexts, gasexplanation will have to be sought in the transcriptional trin is the most extensively studied gastrointestinal horregulation. Accordingly, the promoters of the otherwise mone also with regard to molecular and cellular biology, homologous gastrin and CCK genes display marked differ-including cell-specific prohormone processing. Almost evences in number and types of regulatory sites. The CCK ery tissue in which progastrin is expressed has its own gene promoter contains unusually many regulatory sites, characteristic processing pattern. Four different patterns which moreover have been exceedingly well preserved are shown in Fig. 7 . For members of the gastrin family, during evolution (174, 206, 256) . Hence, the restrictive the processing varies with respect to endoproteolytic proexpression of the CCK gene appears to be a carefully cessing and with respect to amino acid derivatizations and highly differentiated process conserved over several such as tyrosyl sulfations and phenylalanyl amidations hundred million years. In contrast, the gastrin gene pro- (Figs. 5-7) . In this context, it is worth realizing that the moter has less well-preserved regulatory elements (27, 38, different types of processing may influence each other, 119, 206, 256) , which may contribute to explain the more presumably by changing the affinity for the various propromiscuous expression.
cessing intermediates as substrate for the processing enzymes. Thus tyrosyl sulfation, the earliest posttranslational modification for the gastrin family of prohormones D. Cell-Specific Prohormone Processing (Fig. 6) , increases the efficiency of the endoproteolytic cleavage (39, 40, 123) . The more efficient the endoproteoCell-specific gene transcription is the very basis for lytic cleavage is (i.e., the shorter the peptide substrates), the function of multicellular organisms. However, for gasthe more efficient is the COOH-terminal amidation protrointestinal hormones and other regulatory peptides, cess (J. R. Bundgaard and J. F. Rehfeld, unpublished data), gene and prohormone structures are often so complex which is the final modification, decisive for receptor bindand the posttranscriptional and posttranslational processing phases so elaborated (Figs. 4 and 6 ) that the phe-ing and bioactivity. Recently, much attention has been devoted to cells a spillover of gut hormonal peptides released from peripheral neurons may be transported via blood, analogous to that express and process progastrin, but only to glycineextended gastrins. Glycine-extended gastrins are the im-other extraintestinal neuropeptides. It is also possible that some peptidergic neurons expressing gut hormonal pepmediate precursors of the carboxyamidated gastrins in the normal processing pathway (Fig. 6 ). Until recently, tides like some hypothalamopituitary neurons release the peptides directly to blood vessels. Second, as suggested amidated gastrins have been considered to be the only bioactive forms of gastrin. A few years ago it was, how-by Feyrter (74) already in the 1930s and in the wake of the discovery of the morphological substrate for paracrine ever, shown that epithelial cells in colorectal carcinomas synthesize glycine-extended gastrins but no amidated gas-secretion (i.e., somatostatin cells that project short cytoplasmatic processes to neighboring cells, Ref. 138) , it has trin (48, 173, 221) , apparently because the cells do not express the amidation enzyme complex. This observation been shown that there are paracrine cells for other gut hormones in the small intestinal mucosa (136) . These cells raised the question of whether glycine-extended gastrins in spite of their lack of effect on gastric acid secretion carry peptidergic granules through cytoplasmatic extensions to specific target cells in the neighborhood. Para-(105) might act as local, autocrine growth factors. Some evidence has been reported in favor of this idea. Thus crine cells can be conceived as hybrids of classical endocrine cells and neurons. It is consequently possible that there are reports of trophic effects of glycine-extended gastrins on AR4-2J and Swiss 3T3 cells (125, 172, 215, also a local spillover of peptides from paracrine cells may reach the circulation. 242). Until the growth-mediating receptor specific for glycine-extended peptides has been structurally identified Self-stimulation or autocrine secretion was described first by Sporn and Todaro (226) and subsehowever, it is probably too early to take glycine-extended peptides for growth factors. If, however, the receptor quently substantiated by others (53, 111, 225) . By autocrine secretion cells stimulate their own growth. Troeventually is identified, it would add a new dimension to the phenomenon of cell-specific processing for the many phic peptides bind to specific receptors in the membranes of cells in which they are also synthesized amidated gut hormones and regulatory peptides.
As already discussed, cell-specific processing reflects (Fig. 8) . Autocrine secretion is supposed to play a decisive role in tumor and cancer development (225) . The one of the possibilities for utilization of one gene for synthesis of several bioactive peptides. In addition to the first example was small-cell bronchogenic cancers, which were stimulated by autocrine secretion of GRP cell-specific ways in which prohormones belonging to the gastrin family are processed (Fig. 7) , prohormones such (53, 145) . Recent evidence suggests that the growth of certain cultured bronchial carcinoma cells (213) , colon as proglucagon that contain different hormone sequences may be processed by a different principle. Similarly, most carcinoma cells (111, 112) , gastric carcinoma cells (254), and pancreatic tumor cells (19, 214, 253) is stimuprohormones identified in gut endocrinology undergo some kind of cell-specific processing.
lated by autocrine secretion of gastrin and that growth of certain human pancreatic cancers and cell lines is stimulated by CCK peptides (100, 219, 220).
E. Cell-Specific Peptide Release
Cellular release of gastrointestinal peptides also occurs in a fifth way that cannot be ascribed to any of the four above-mentioned ways (Fig. 8) . As already To understand the specific effects of the different gastrointestinal peptides, it is necessary to realize that the mentioned, spermatogenic cells in mammals other than humans express the CCK gene (180) , whereas human different types of cells in which the respective genes are expressed also release the peptides in different ways (Fig. spermatogenic cells express the gastrin gene (208) . In spermatozoans, CCK or gastrin peptides are fully car-8). As mentioned in section I, secretion of gastrointestinal hormones was until approximately 20 years ago supposed boxyamidated and concentrated in the acrosome. In accordance with the acrosomal reaction, the peptides are to be endocrine only, i.e., secretory granules from the endocrine cells in the gastrointestinal mucosa emptied released from the spermatozoan by contact with the jelly coat of the egg, and subsequently bound to receptheir peptides in surrounding capillaries after appropriate stimulations.
tors in the egg membrane. So far, CCK or gastrin receptors have not yet been demonstrated in mammalian egg In contrast to the systemic release of gastrointestinal hormones from classical endocrine cells, three alternative cell membranes, but availability of probes for the CCK and gastrin receptors (132, 252) makes a search for routes of secretion to neighboring cells and one to the secretory cell itself have been discovered during the last them feasible in a foreseeable future. Acrosomal release may prove to be one of the most important mechanisms 20 years (Fig. 8) . First, the peptides synthesized in neurons are released from synaptosomal vesicles in the nerve of secretion for gut peptides if fertilization of the egg (i.e., the beginning of life in a ontogenetic sense) turns terminals to the receptors of adjacent target cells, i.e., neurotransmitter or neurocrine release. It is possible that out to require such peptides. We suggest that the release 8 . Five types of cell-specific release of regulatory gut peptides: 1) endocrine release to capillaries from classic endocrine cells in gastrointestinal mucosa; 2) neurocrine release from central or peripheral neurons to synaptic cleft; 3) paracrine release to neighboring cells through short cellular processes; 4) paracrine cells are often of closed type, which do not reach intestinal lumen, and autocrine release to receptors on membrane of same cell that synthesizes peptides; and 5) spermiocrine release from acrosomal granule of spermatozoans to receptors on egg cell membrane.
lations. It is possible and even likely that most regulatory of bioactive peptides from acrosomal granules is named peptides (hormones, neurotransmitters, growth factors, spermiocrine release (Fig. 8) .
cytokines) at least at some stage in the phylo-or ontogenetic development are expressed in the gut. Hence, the IV. PERSPECTIVE development of gastrointestinal endocrinology as depicted in Figure 1 may on the one hand continue its expoGastrointestinal endocrinology has over the last nential growth with a broad definition of regulatory pepquarter of this century developed from a small appendix tides. On the other hand, such extension almost deprives to endocrinology consisting of three distinct peptides the concept of gastrointestinal endocrinology of its meanwith local secretagogue functions, to a biological disci-ing, and that is exactly what it is all about. Gastrointestinal pline of its own comprising a multitude of more than hormones should be viewed not only as local hormones 100 bioactive peptides, which are expressed in a con-of interest for digestive physiologists and clinical gastrotrolled cell-specific manner all over the body. The pep-enterologists. Instead, gastrointestinal hormones are intetides participate in intercellular regulation from local grated participants in the coordination and regulation of control of growth and differentiation to acute systemic many or most functions in vertebrates, and perhaps also effects. Thus travelers on the journey beginning in the in invertebrates. Thus it is in retrospect not surprising early 1970s have witnessed a revolution that has that classic gut hormones today are studied not only in changed fundamental concepts and opened wide per-physiology, pharmacology, biochemistry, and cell biology, spectives in physiology and pathophysiology.
but also by psychologists, psychiatrists, zoologists, molecToday, gastrointestinal hormones must be viewed as ular oncologists, diabetologists, and others. highly conserved general intercellular messengers. There
The most important developments to come for gut are no obvious boundaries between their role in food in-hormone research are likely to occur in basic cell biology with applications to clinical oncology and in neurobiology take and digestion and their function in other bodily regu- cancers and common psychiatric diseases. 
